Prevalence and Prognostic Implications of Frailty in Transcatheter Aortic Valve Replacement

Palina Piankova; Jonathan Afilalo

doi:10.1016/j.ccl.2019.09.011

Prevalence and Prognostic Implications of Frailty in Transcatheter Aortic Valve Replacement

Cardiol Clin. 2020 Feb;38(1):75-87. doi: 10.1016/j.ccl.2019.09.011.

Authors

Palina Piankova¹, Jonathan Afilalo²

Affiliations

¹ Centre for Clinical Epidemiology, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, H-411, Montreal, Quebec H3T1E2, Canada.
² Centre for Clinical Epidemiology, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, H-411, Montreal, Quebec H3T1E2, Canada; Division of Cardiology, Geriatric Cardiology Fellowship Program, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine Road, E-222, Montreal, Quebec H3T 1E2, Canada. Electronic address: jonathan.afilalo@mcgill.ca.

PMID: 31753179
DOI: 10.1016/j.ccl.2019.09.011

Abstract

Assessment of frailty has become engrained in the preprocedural evaluation of older adults referred for transcatheter aortic valve replacement. Addition of frailty and disability to clinical risk scores results in improved discrimination for short- and midterm mortality and identifies patients less likely to be discharged home and more likely to report worsening quality of life over the ensuing 6 to 12 months. In clinical practice, frailty can be evaluated by a tiered approach starting with a brief screening tool such as the Essential Frailty Toolset.

Keywords: Frailty; Older adults; Transcatheter aortic valve replacement.

Publication types

Review

MeSH terms

Aortic Valve Stenosis / complications*
Aortic Valve Stenosis / surgery*
Frailty / epidemiology*
Humans
Prevalence
Prognosis
Transcatheter Aortic Valve Replacement*